Accolades
Lei Li Named “Life Sciences and Healthcare Lawyer of the Year”
December 8, 2023
Lei Li has been honored as the “Life Sciences and Healthcare Lawyer of the Year” at The Legal 500 China Awards 2023. The awards recognize the “leading firms and lawyers together with the younger rising talent who are part of China’s extensive and complex legal market.”
Lei Li is the Managing Partner of Sidley’s Shanghai and Beijing offices. He advises clients on a broad range of regulatory, compliance, and government enforcement matters in China, with a particular focus on the life sciences industry and is one of the most accoladed legal practitioners in China in his areas of practice. Lei has advised multinational and local Chinese pharmaceutical and medical device companies on matters across the full spectrum of the industry and has handled some of the largest and most representative matters in the industry in China in the last decade.
Lei Li is the Managing Partner of Sidley’s Shanghai and Beijing offices. He advises clients on a broad range of regulatory, compliance, and government enforcement matters in China, with a particular focus on the life sciences industry and is one of the most accoladed legal practitioners in China in his areas of practice. Lei has advised multinational and local Chinese pharmaceutical and medical device companies on matters across the full spectrum of the industry and has handled some of the largest and most representative matters in the industry in China in the last decade.
Contacts
Offices
Capabilities
Suggested News & Insights
U.S. Drug Pricing Year in Review: Reflections on 2025 and Getting Ready for 2026December 12, 2025BIOSECURE Act Included in the FY2026 National Defense Authorization ActDecember 12, 2025Sidley Ranked in Chambers Asia-Pacific 2026December 11, 2025U.S. Drug Pricing Year in Review: Reflections on 2025 and Getting Ready for 2026December 11, 2025What the U.S.–UK Drug Pricing Agreement Reveals About How MFN Drug Policy Could Impact the UK and EUDecember 10, 2025What the U.S.–UK Drug Pricing Agreement Reveals About How MFN Drug Policy Could Impact the UK and EUDecember 10, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
